Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Are Potential Biosimilar Sponsors Still Hesitant About The Pathway Despite Expected Growth?

Mar 04 2013

• By Derrick Gingery

Related Content

Waxman Says Biosimilar Pathway Will Push Applicants To BLA

Nov 22 2010

Watson Biosimilar Tie Up With Itero Plays Into Women's Health Expertise

Jul 19 2010

FDASIA Is Signed, Not That White House Wanted Anyone To Notice

Jul 16 2012

Generic Industry Specialization, Consolidation Driven By Rising Product Complexity

Mar 04 2013

CMS 2012 Budget Looks To Biosimilars, Brand/Generic Deals To Offset Costs

Feb 21 2011

Biosimilar Meeting Requests Increase, But FDA Cancels Some For Lack Of Data

Dec 12 2012

Draft Guidances For 2013 Will Grapple With Biosimilars, Track and Trace, Compounding

Feb 11 2013

Related Companies

Allergan plc

Merck KGaA

Allergan plc

IQVIA Holdings Inc.

Viatris Inc.

Amgen, Inc.

Genentech, Inc.

Additional Topics

United States Drug Approval Standards BioPharmaceutical

More from United States

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window